CORE is our flagship event each year, attracting unparalleled access to industry leaders, decision-makers, and engaged participants who are passionate about life sciences and drug & device development leaders. This year's platinum sponsor, ScienceMedia, Inc. (SMi) offers insights to the "butterfly effect," highlights how a small, seemingly insignificant action can trigger a cascade of events with significant consequences, even in the high-stakes world of clinical trials. Read more at: https://hubs.la/Q02_QcWh0
Halloran Consulting Group, Inc.
Business Consulting and Services
Boston, Massachusetts 7,939 followers
About us
Halloran Consulting Group, a ProductLifeGroup company, is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support in the pharmaceutical, biotechnology, and medical device sectors in the United States. Founded in 1998 by Laurie Halloran, the company is known for offering comprehensive solutions to help clients navigate complex regulatory environments, optimize operations, and accelerate product development. The Halloran team empowers clients to achieve critical business milestones, ensure product quality and safety, and maintain competitive advantage in highly regulated environments. The company has a bi-coastal presence with offices located in Boston, MA and San Diego, CA. Their team of subject matter experts takes a customized approach to each engagement, effectively guiding their clients toward their next pivotal moment. They are trusted industry partners whose expertise offers operational excellence and fosters innovation across the life sciences ecosystem. Their goal is to support clients and the patients they serve.
- Website
-
http://www.hallorancg.com
External link for Halloran Consulting Group, Inc.
- Industry
- Business Consulting and Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Specialties
- Regulatory Strategy/Submissions, Quality Systems, Clinical Development, Due Diligence, TMF, Organizational Development, Program Management, Gap Analysis, Clinical Finance, Change Management, Vendor Management, Inspection Readiness, Training, Technology Adoption, Clinical Trials, Clinical Research, Virtual Clinical Trials, Organizational Solutions, Data Management, Technology Implementation, Strategy Management, and Program Leadership
Locations
-
Primary
22 Thomson Pl
Boston, Massachusetts 02210, US
-
3040 Science Park Rd
San Diego, California 92121, US
Employees at Halloran Consulting Group, Inc.
Updates
-
We're looking forward to be a part of one of the premier industry events this coming January. Let's connect! Reach out at https://hubs.ly/Q02_qBY30 We're ready to be your end-to-end life sciences consulting services partner! #JPM2025
-
As we begin to close out 2024 (where does a year go?) we're sharing some of our "best of" content. The ICH E6(R3) draft guideline for Good Clinical Practice (GCP), the global standard for clinical trial conduct is currently under public consideration. Check out our webinar on-demand. Register and a link will be sent to your email. https://hubs.la/Q02--JVN0
-
Mark your calendar 📆 We sure have! January 13-15, #BiotechShowcase, #JPM2025. Share your insights on the policy and regulations you see impacting our life sciences and biotech sectors in the coming year! Learn more about the team representing Halloran Consulting Group, Inc., a ProductLife Group company, and Commercial Eyes Pty Ltd by visiting, https://hubs.la/Q02_t6s40
-
As part of our 2024 Best Of Series content, watch our on-demand webinar: Inspection Readiness: A Failure to Plan is a Plan to Fail. https://hubs.la/Q02-s5NN0
On-Demand: Inspection Readiness A Failure to Plan is a Plan to Fail
-
Based on feedback from nearly 100 industry leaders, we’ve outlined the top inspection readiness fears and a seven step process for preparation. Download our infographic here. https://hubs.la/Q02-Pj7g0
-
As we continue our BEST OF SERIES in 2024, we're looking at the U.S. Food and Drug Administration (FDA) Form 483, issued to a company’s management at the conclusion of an inspection when an investigator(s) has observed any conditions that in their judgment may constitute a violation and/or objectionable conditions. Read Lyn Agostinelli's expertise at https://hubs.la/Q02ZYzRT0
-
It's the BEST OF series as we close out 2024. Trial Master Files (TMF) are a critical component of a clinical trial demonstrating compliance with regulatory requirements and Good Clinical Practice (GCP). Read insights from Halloran Consulting Group, Inc.'s Michelle Peter. Want to learn more? Contact us! https://lnkd.in/ehPKxNuK
-
Bandwidth, access to expertise, and ability to quickly scale up and down are business drivers. Halloran Consulting Group, Inc., now a ProductLife Group Company, offers biopharma and biotech companies around the globe the right solution, at the right time, accelerating time to market. Learn more by contacting us: https://hubs.la/Q02YTJnH0 #biopharma #biotech #regulatory